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Contents: It is well documented that serious side effects or toxic interactions may occur after 
the administration of some drugs and/or medicines with the concurrent use of 
alcohol (ethanol). Most of these interactions are attributable to pharmacokinetic 
changes caused by alcohol in the hepatic drug metabolic pathways catalysed by the 
cytochrome P450 system. What is not so well known is the potential effect of drugs 
and medicines on the activity of the liver alcohol dehydrogenase (ADH). Liver 
cytosolic ADH, the major catabolizing enzyme of alcohol, catalyzes the reversible 
oxidation of ethanol to acetaldehyde with the corresponding reduction of NAD to 
NADH. The knowledge of ADH-xenobiotics interactions would be very important 
because if a drug significantly inhibits liver ADH it will prevent ethanol to be 
eliminated at normal rates and blood alcohol concentration (BAC) would 
concomitantly increase. In these situations, it should be definitely known by 
physicians, pharmacists and patients that drugs with that kind of action present an 
increased risk of slowing alcohol metabolism. This might then result in potentially 
toxic plasma alcohol concentrations with behavioural impairment and social, legal 
and forensic implications. In order to evaluate the possible interactions between 
commonly prescribed medicines and ethanol metabolism, a spectrophotometric 
method was developed to study the alcohol dehydrogenase activity of rat liver 
homogenates by monitoring NADH formation at 340 nm in the presence and in the 
absence of different xenobiotics. Enzyme activity was calculated from the linear 
increase in A340nm after ethanol addition1 in the presence of tramadol, 
flunitrazepam, alprazolam and propanonol. 4-Methylpyrazole, a well-known specific 
inhibitor of ADH, was used as a positive control. Results will be presented that 
demonstrate the efficiency of the method and the preliminary data of the interaction 
between ADH and the tested substances.  
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